Vir Biotechnology, Inc. (VIR)
6.785
+0.24
(+3.59%)
USD |
NASDAQ |
Dec 11, 13:17
Vir Biotechnology Market Cap: 943.96M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vistagen Therapeutics, Inc. | 164.70M |
| Bristol Myers Squibb Co. | 103.99B |
| NovaBay Pharmaceuticals, Inc. | 343.38M |
| Palatin Technologies, Inc. | 26.96M |
| Theriva Biologics, Inc. | 7.828M |
Market Cap Related Metrics
| PS Ratio | 55.50 |
| Price to Book Value | 1.186 |
| Price | 6.785 |
| Earnings Yield | -53.35% |